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OBJECTIVE—Diet-induced obesity (DIO) is linked to peripheral
insulin resistance—a major predicament in type 2 diabetes. This
study aims to identify the molecular mechanism by which DIO-
triggered endoplasmic reticulum (ER) stress promotes hepatic
insulin resistance in mouse models.
RESEARCH DESIGN AND METHODS—C57BL/6 mice and
primary hepatocytes were used to evaluate the role of LIPIN2
in ER stress-induced hepatic insulin resistance. Tunicamycin,
thapsigargin, and lipopolysaccharide were used to invoke acute
ER stress conditions. To promote chronic ER stress, mice were
fed with a high-fat diet for 8–12 weeks. To verify the role of
LIPIN2 in hepatic insulin signaling, adenoviruses expressing
wild-type or mutant LIPIN2, and shRNA for LIPIN2 were used
in animal studies. Plasma glucose, insulin levels as well as hepatic
free fatty acids, diacylglycerol (DAG), and triacylglycerol were
assessed. Additionally, glucose tolerance, insulin tolerance, and
pyruvate tolerance tests were performed to evaluate the meta-
bolic phenotype of these mice.
RESULTS—LIPIN2 expression was enhanced in mouse livers by
acute ER stress–inducers or by high-fat feeding. Transcriptional
activation of LIPIN2 by ER stress is mediated by activating tran-
scription factor 4, as demonstrated by LIPIN2 promoter assays,
Western blot analyses, and chromatin immunoprecipitation
assays. Knockdown of hepatic LIPIN2 in DIO mice reduced fasting
hyperglycemia and improved hepatic insulin signaling. Conversely,
overexpression of LIPIN2 impaired hepatic insulin signaling in
a phosphatidic acid phosphatase activity–dependent manner.
CONCLUSIONS—These results demonstrate that ER stress–
induced LIPIN2 would contribute to the perturbation of hepatic
insulin signaling via a DAG-protein kinase C ´–dependent manner
in DIO mice. Diabetes 60:1072–1081, 2011
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xcessive intake of diets rich in fat results in the
increased incidence of obesity-associated pe-
ripheral insulin resistance. Accumulation of free
fatty acids under this condition triggers the
generation of second messengers such as diacylglycerol
(DAG) and ceramide or their metabolites, which in turn
activates serine/threonine kinases that directly reduce in-
sulin receptor/insulin receptor substrate–dependent sig-
naling cascades in insulin-sensitive tissues, including the
liver and muscle (1–3). Hyperglycemia is pronounced under
the insulin resistance in part as a result of the uncontrolled
hepatic glucose production, which would ultimately lead to
the progression of type 2 diabetes (4).
Endoplasmic reticulum (ER) stress is elicited by con-
ditions, such as inﬂammation and nutrient overloads that
perturb normal ER homeostasis. Abnormal accumulation
of unfolded proteins causes a collective signaling cascade
termed unfolded protein response (UPR) in that setting,
which leads to the release of GRP78 and the activation of
three classes of signaling cascades to relieve such ER-
associated stress (5): 1)p r o t e i nk i n a s eR N A –like ER-
associated kinase (PERK)-eukaryotic translation initiation
factor 2a (eIF2a)-activating transcription factor 4 (ATF4)
pathway; 2) inositol-requiring protein 1a (IRE1a), X-box
binding protein 1 (XBP1) pathway; and 3) activating tran-
scription factor 6 (ATF6) pathway.
Activation of PERK is critical in the attenuation of
general translation under ER stress by phosphorylation/
inactivation of eIF2a, and it also activates the translation
of certain UPR gene clusters by activation of ATF4 (6).
IRE1a uses its endoribonuclease activity to mediate a
generation of splicing variants of XBP1, producing a po-
tent basic leucine zipper (bZIP) transcriptional activator
for enhancement of UPR genes (7). Finally, UPR also
activates another bZIP transcription factor, ATF6, by pro-
moting its proteolytic cleavage and liberation from the
lumen of the ER. The resultant nuclear ATF6 can then
enter into the nucleus and activate a subset of genes that
are required for relieving ER stress conditions (8,9). Inter-
estingly, although treatment of acute ER stress–inducers
such as thapsigargin or tunicamycin could induce all of
these signaling pathways in vitro, it was shown that only
the PERK-dependent pathway is persistently activated
under the obesity-induced chronic ER stress in rodents,
suggesting the presence of a distinctive role for each
pathway in response to differential stimuli in a physiologi-
cal setting (10–13).
The LIPIN family of proteins constitutes the mammalian
type 2 phosphatidic acid phosphatase (PAP) in mammals
(14). LIPIN1, a founding member of this family, is linked to
lipid metabolism and insulin signaling and is a gene
product responsible for the pathophysiology of ﬂd mice,
presumably affecting the normal function of adipose tis-
sues (15,16). Expression of LIPIN1 in the liver is less
pronounced than in other tissues. However, multiple roles
have been proposed for LIPIN1 in the regulation of hepatic
lipid metabolism, suggesting that the hepatic function
of this protein is critical for the mammalian lipid homeo-
stasis. LIPIN1 possesses a coactivator activity for nuclear
receptors such as peroxisome proliferator–activated
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ORIGINAL ARTICLEreceptor a, and together with peroxisome proliferator–
activated receptor coactivator-1a, could enhance fatty acid
b-oxidations in the liver in the normal context (17). In
addition, LIPIN1 might also be involved in the process of
hepatic triacylglycerol (TAG) secretion in the normal
physiological context, although the exact mechanism has
not been elucidated to date (18,19). We have recently
shown that LIPIN1 expression is signiﬁcantly enhanced in
the livers from mouse models of genetic obesity and diet-
induced obesity (DIO), and its PAP function is critical in
the progression of hepatic insulin resistance by promoting
DAG-protein kinase C (PKC) ´–dependent inactivation of
insulin receptor-mediated signaling cascades (20). These
data suggest that abnormal regulation of LIPIN1 activity
might be detrimental to the hepatic lipid homeostasis un-
der pathophysiological conditions.
All three LIPIN proteins possess domains for PAP ac-
tivity that are able to catalyze the conversion of phos-
phatidic acid to DAG, at least in vitro (21). Interestingly,
LIPIN isoforms display differential tissue distributions.
Whereas LIPIN1 is predominantly expressed in adipose
tissues or muscle and less so in the liver and neuronal
tissues, LIPIN2 is exclusively expressed in the liver and
kidney. LIPIN3 is rather ubiquitously expressed, but its
expression is almost absent in the liver, showing that this
isoform may not function as an important PAP enzyme in
the liver under physiological conditions (21,22). Although
LIPIN2 is linked to the Majeed syndrome in humans, the
exact physiological roles for LIPIN2 are not well studied in
those clinical studies (23). Recently, LIPIN2 expression is
also shown to be increased in the genetic mouse models of
obesity (ob/ob and db/db mice), and is critical in the he-
patic TAG production that is associated with its PAP ac-
tivity (22), prompting us to investigate the exact molecular
mechanism for the obesity-induced activation of LIPIN2
expression and its signiﬁcance in the progression of in-
sulin resistance in such conditions.
Here we report that LIPIN2 expression is induced by
both acute and chronic ER stress conditions. ATF4, one of
the major transcription factors that mediates ER stress-
dependent signaling, is responsible for the transcriptional
activation of LIPIN2 in the liver. Adenovirus-mediated
knockdown of LIPIN2 in the liver greatly reduces hepatic
DAG levels as well as hyperglycemia and insulin resistance
in DIO mice. Conversely, overexpression of LIPIN2 pro-
motes hepatic insulin resistance, which is associated with
its PAP activity. These results demonstrate that chronic
ER stress–induced LIPIN2 would contribute to the pro-
gression of hepatic insulin resistance in rodents.
RESEARCH DESIGN AND METHODS
Plasmids and recombinant adenoviruses. Promoter sequences for LIPIN2
were PCR-ampliﬁedfrom mouse genomicDNA andwereinsertedinto thepGL4
basic vector (Promega). The coding sequence for mouse ATF4 was ampliﬁed
from mouse hepatic cDNAs and inserted into pcDNA3-ﬂag vectors to generate
pcDNA3-ﬂag-ATF4. The expression vector for dominant-negative ATF4 was
generated as described (24). Adenoviruses for LIPIN2 and pcDNA3-ﬂag-LIPIN2
were described previously (20). The LIPIN2 mutant (D712E, D714E) was se-
lected based on the homology between LIPIN1 and LIPIN2 and was generated
by site-directed mutagenesis as described (17,20). Adenoviruses expressing
green ﬂuorescent protein (GFP) only and the nonspeciﬁc RNA interference
control (unspeciﬁc [US]) were described previously (25,26). Adenoviruses for
ATF4 and short hairpin RNA for LIPIN2 (shLIPIN2) were generated as de-
scribed previously (20,27).
Animal experiments. Four-week-old male C57BL/6 mice (for the DIO model)
were purchased from Charles River Laboratories, and were fed a high-fat diet
(60 kcal% fat diet; D12492 of Research Diets, Inc.) for 12 weeks in a speciﬁc
pathogen-free facility at the Sungkyunkwan University School of Medicine
(12:12 h light-dark cycle). Recombinant adenovirus (0.5 3 10
9 plaque-forming
units for overexpression, and 1 3 10
9 plaque-forming units for short hairpin
RNA) was delivered by tail-vein injection. To measure fasting blood glucose
levels, animals were fasted for 4 h with free access to water. For the glucose
and pyruvate tolerance tests, mice were fasted for 4–16 h and then injected
intraperitoneally with 2 g/kg body wt of glucose (on day 4 post-adenoviral
injection) or pyruvate (on day 6 after adenoviral injection) (20). For the insulin
tolerance test, mice were fasted for 4 h and then injected intraperitoneally
with 1 unit/kg body wt of insulin on day 5 after adenoviral injection. Plasma
glucose or insulin was measured on blood drawn from the tail vein at desig-
nated time points. To activate the insulin signaling pathway, either PBS (for
control) or insulin (0.5 unit/kg body wt) was injected intraperitoneally for
10 min before the collection of the liver for further analyses on day 7 post-
adenoviral injection. Seven-week-old male C57BL/6 mice (for the intraperitoneal
injection of ER stress inducers) were purchased from Charles River Labora-
tories. ER stress was induced by intraperitoneal injection of tunicamycin (2.5
mg/g body wt for 2 h) or lipopolysaccharide (LPS) (3 mg/ g body wt for 8 h). All
procedures were approved by the Sungkyunkwan University School of Med-
icine Institutional Animal Care And Use Committee (IACUC).
Quantitative PCR. Total RNA from either primary hepatocytes or mouse liver
was extracted using RNeasy Mini Kit (Qiagen). cDNAs generated by Super-
script II enzyme (Invitrogen) were analyzed by quantitative PCR using a SYBR
green PCR kit and TP800, Thermal Cycler DICE Real Time System (TAKARA).
All data were normalized to ribosomal L32 expression. Information for primers
is described in Supplementary Table 1.
Western blot analyses. Whole cell extracts were prepared using radio-
immunoprecipitation assay buffer containing protease inhibitor cocktails (Cal-
biochem). Western blot analyses on 50–100 mg of protein were performed as
described (28). Information for antibodies is described in Supplementary Table 2.
Culture of primary hepatocytes. Primary hepatocytes were prepared from
6- to 8-week-old C57BL/6 mice as described previously (29). Cells were plated
with medium 199 supplemented by 10% FBS, 10 units/mL penicillin, 10 mg/mL
streptomycin, and 10 nmol/L dexamethasone. After attachment, cells were
infected with various adenoviruses as indicated in ﬁgure legends. Subsequently,
cells were maintained in the same media without FBS overnight and treated
with 1.25 mg/mL tunicamycin, 0.5 mmol/L thapsigargin, 100 nmol/L phosphatidic
acid, or 100 nmol/L insulin for designated time points in the ﬁgure legends.
Transfection assays. HepG2 cells were maintained with Ham’s F12 medium
supplemented with 10% FBS, 10 units/mL penicillin, and 10 mg/mL streptomycin.
Each transfection was performed with 300 ng of luciferase construct, 50 ng of
b-galactosidase plasmid, and 30–100 ng of expression vector for wild-type or
dominant-negative ATF4 (24) using TransIT-LT1 transfection reagent (Mirus).
Chromatin immunoprecipitation assays. Nuclear isolation, cross-linking,
and chromatin immunoprecipitation assays on primary mouse hepatocyte
samples were performed as described previously (30). Precipitated DNA frag-
ments were analyzed by PCR using primers against relevant mouse promoters.
Measurement of metabolites. For the measurement of metabolites, 4-h
fasted mice were killed at day 7 post-adenoviral injection. Blood glucose for
basal conditions and during glucose tolerance test was monitored from tail-vein
blood using an automatic glucose monitor (One Touch, LifeScan). Hepatic
lipids were extracted essentially as reported previously (31). Plasma and he-
patic triglycerides and nonesteriﬁed fatty acids were measured by colorimetric
assay kits (Wako). Insulin was measured by Mouse Insulin ELISA Kit
(ALPCO). Hepatic DAGs were measured by liquid chromatography tandem
mass spectometry with Atmosphere Pressure Chemical Ionization (APCI)
source using homogenates from 30 mg of liver tissues as described (32).
Statistical analyses. Results are shown as mean 6 SEM. The comparison of
different groups was carried out using two-tailed unpaired Student t test, and
differences at or under P , 0.05 were considered statistically signiﬁcant and
reported as in legends.
RESULTS
ER stress induces LIPIN2 expression in the liver.
Recent reports indicated that unresolved ER stress could
promote hepatic lipid synthesis by inducing key enzyme
genes such as SREBP-1c and DGAT2 (33), prompting us to
investigate whether expression of LIPIN2, a liver-enriched
mammalian PAP for DAG synthesis, is also affected.
Tunicamycin or LPS induces expression of UPR genes
such as ATF4, CHOP, GRP78, and the spliced form of
XBP1 in the mouse liver (Fig. 1A and B). Interestingly, we
also observed enhanced expression of most lipogenic
genes including SREBP-1c, FAS, and LIPIN2. Indeed,
LIPIN2 protein levels are also enhanced under these
D. RYU AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1073FIG. 1. ER stress induces LIPIN2 expression in vivo. A: Wild-type C57BL/6 mice were injected intraperitoneally with either DMSO or tunicamycin
(2.5 mg per g body wt, n = 4 per group), and livers were collected 2 h post-injection. Quantitative PCR analysis was performed with hepatic RNAs.
B: Saline (as a vehicle) or LPS (3 mg per g body wt, n = 5 per each group) was injected intraperitoneally, and livers were collected 8 h post-
injection. Quantitative PCR analysis was performed with hepatic RNAs. C: Western blot analysis was performed with lysates from mouse livers as
in A. Representative data from three independent experiments are shown. D: Western blot analysis was performed with lysates from mouse livers
as in B. Representative data from three independent experiments are shown. E and F: Hepatic RNAs for quantitative PCR analysis (E) and lysates
for Western blot assay (F) were prepared from mice on either normal chow diet or high-fat diet (60 kcal% fat for 12 weeks, D12492 [Research
Diets] n = 5 per group). Representative data from three independent experiments are shown. Error bars indicate SEM. Statistical signiﬁcance was
assessed by two-tailed Student t test. *P < 0.05; **P < 0.01. sXBP1, spliced XBP1; uXBP1, unspliced XBP1.
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DAG synthesis via activation of LIPIN2 (Fig. 1C and D and
Supplementary Fig. 1). To verify the effect of ER stress on
LIPIN2 expression in more physiological settings, we fed
mice with a high-fat diet for 12 weeks to induce chronic ER
stress conditions. Hepatic LIPIN2 expression is higher in
high-fat diet–fed mice than in control mice (Fig. 1E and F
and Supplementary Fig. 1). Interestingly, unlike the acute
ER stress conditions, only a subset of UPR pathways
(p-PERK, ATF4, CHOP) is activated under chronic con-
ditions. These data suggest that both acute and chronic ER
stress could induce LIPIN2 expression in the mouse liver.
ATF4 mediates ER stress–dependent activation of
LIPIN2 transcription. To directly test whether ER stress–
mediated induction of LIPIN2 expression is primarily via
intrahepatic signaling pathways, we treated primary hepa-
tocytes with tunicamycin or thapsigargin. Indeed, LIPIN2
expression is enhanced by acute ER stress inducers (Fig. 2A
and Supplementary Fig. 2). Next, we wanted to test whether
ATF4 or CHOP, two transcription factors that are induced by
both acute and chronic ER stress conditions, could activate
LIPIN2 expression. Because CHOP is a direct transcriptional
target of ATF4, we prepared expression plasmids for ATF4
and CHOP, and transfected each construct in the cultured
cells. Overexpression of CHOP does not signiﬁcantly
induce LIPIN2 expression. On the other hand, over-
expression of ATF4 enhances protein levels of LIPIN2,
suggesting that ATF4, but not CHOP, is responsible for
promoting expression of LIPIN2 (Supplementary Fig. 3).
Infection of adenovirus for ATF4 also mimics the effect of
ER stress–dependent induction of LIPIN2 mRNA, support-
ing the notion that ATF4 could function as a transcriptional
activator that mediates ER stress–dependent induction of
LIPIN2 expression in hepatocytes (Fig. 2B). To further de-
termine whether ATF4 could regulate LIPIN2 expression at
the transcription level, we performed LIPIN2 reporter assays.
We observed about threefold induction of LIPIN2 promoter
activity by thapsigargin treatment (Fig. 2C). Further deletion
analysis reveals that ATF4 can activate promoter activity of
mouse LIPIN2 (Fig. 2D), which is inhibited by cotransfection
of ATF4-DN (Supplementary Fig. 4). Finally, occupancy of
ATF4 over its binding site on the LIPIN2 promoter was
conﬁrmed by chromatin immunoprecipitation assay, and
ATF4 binding is enhanced signiﬁcantly both by thapsigargin
and tunicamycin treatment (Fig. 2E and F). These data
support the notion that ER stress–dependent induction of
LIPIN2 is mediated mainly by ATF4 at the transcription
level.
Depletion of LIPIN2 reduces glucose intolerance and
improves insulin sensitivity. Next, we wanted to ad-
dress whether elevated expression of LIPIN2 plays a role
in ER stress–dependent signalings in mice. To this end, we
generated adenovirus-expressing shLIPIN2 (Ad shLIPIN2)
and injected it into mice. Knockdown of LIPIN2 in normal
chow-fed mice slightly reduces blood glucose levels or
hepatic triglyceride levels, although the values do not
reach statistical signiﬁcance (Supplementary Fig. 5). We
thus attempted to test the Ad shLIPIN2 in high-fat diet–fed
mice, in which hepatic LIPIN2 expression is elevated. Indeed,
knockdown of hepatic LIPIN2 in high-fat diet–fed mice
reduces hepatic triglyceride and DAG levels without affect-
ing plasma free fatty acids or triglyceride levels (Fig. 3A–F).
Furthermore, plasma glucose and insulin levels are re-
duced upon LIPIN2 knockdown, suggesting that LIPIN2
might be involved in the perturbation of insulin signaling in
response to high fat–induced chronic ER stress conditions
in the liver (Fig. 3G and H). This notion was further con-
ﬁrmed by glucose and insulin tolerance tests, as these tests
revealed that LIPIN2 knockdown improves glucose in-
tolerance or insulin resistance in high-fat diet–fed mice
(Fig. 4A–C and Supplementary Fig. 6). Of note, plasma
insulin levels between control and LIPIN2-knockdown
animals are not signiﬁcantly different during the glucose
tolerance test, showing that improved glucose tolerance
upon LIPIN2 knockdown might stem from the enhanced
ability to clear excessive plasma glucose without affecting
insulin secretion (Fig. 4B). Depletion of LIPIN2 also
reduces hepatic glucose production in response to the in-
jection of gluconeogenic precursors and expression levels
for gluconeogenic enzymes, showing a sign of restoration
in glucose homeostasis in this setting (Fig. 4D and E and
Supplementary Fig. 7).
Improvement of insulin signaling by LIPIN2 knockdown
was veriﬁed by Western blot analysis, which showed the
increased tyrosine phosphorylation of insulin receptor or
insulin receptor substrate 1, serine phosphorylation of
AKT and GSK3b, and diminished serine phosphorylation of
PKC´ (Fig. 4E and Supplementary Fig. 7). On the other
hand, tyrosine phosphorylation of insulin receptor sub-
strate 2 or p85 levels are not signiﬁcantly affected by
LIPIN2 knockdown, perhaps reﬂecting the presence of
a residual PAP activity by other LIPIN isoforms. In line
with this notion, knockdown of LIPIN2 does not affect the
expression of LIPIN1, which may explain the incomplete
activation of insulin signaling with the acute depletion of
hepatic LIPIN2 (Supplementary Fig. 8). Similar effect on
insulin signaling is also obtained by LIPIN2 knockdown in
primary hepatocytes in the presence of phosphatidic acid,
further corroborating the notion that hepatic LIPIN2
knockdown improves insulin sensitivity in insulin resistant
conditions (Supplementary Figs. 9 and 10).
PAP activity of LIPIN2 is critical in the promotion of
hepatic insulin resistance. Next, we attempted to verify
the importance of PAP function of LIPIN2 in perturbing
hepatic lipid metabolism and insulin signaling under the
ER stress conditions. To this end, we generated adenovi-
rus for wild-type or PAP-mutant LIPIN2 and inject each
virus into the mice. Overexpression of LIPIN2 does not
invoke signiﬁcant changes in blood glucose levels or he-
patic triglyceride levels in normal chow-fed mice com-
pared with PAP mutant LIPIN2 (Supplementary Fig. 11),
suggesting that the presence of a fatty acid–derived pre-
cursor such as phosphatidic acid is critical for the full PAP
activity of LIPIN2. Indeed, hepatic expression of wild-type
LIPIN2, but not mutant LIPIN2, results in higher DAG and
triglyceride levels in the mouse liver without affecting the
plasma fatty acids or triglyceride levels in a PAP function–
dependent manner in high-fat diet–fed mice (Fig. 5A–F).
Expression of LIPIN2 also promotes hyperglycemia and
hyperinsulinemia and perturbs glucose tolerance and in-
sulin sensitivity (Figs. 5G and H and 6A–C), presumably as
a result of the impaired insulin signaling, as evidenced by
reduced tyrosine phosphorylation of insulin receptor, in-
sulin receptor substrate 1, insulin receptor substrate 2, p85
levels, serine phosphorylation of AKT, enhanced serine
phosphorylation of PKC´ and expression of gluconeogenic
enzymes in LIPIN2 mice compared with mice infected with
mutant LIPIN2 or GFP control adenovirus (Fig. 6D and
Supplementary Fig. 12). Unlike the case for LIPIN2 knock-
down, we observed that tyrosine phosphorylation of both
insulin receptor substrate 1 and insulin receptor sub-
strate 2 are similarly affected by LIPIN2 overexpression,
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presence of supra-physiological levels of LIPIN2 in the
liver. Again, plasma insulin levels during the GTT are not
signiﬁcantly different between mice with GFP, wild type or
mutant LIPIN2 (Fig. 6B). Similarly, insulin-dependent in-
crease in serine phosphorylation of AKT is reduced upon
overexpression of enzymatically active LIPIN2 in primary
hepatocytes in response to phosphatidic acid treatment
(Supplementary Fig. 13). Collectively, these data suggest
that PAP function of LIPIN2 is critical in enhancing DAG-
PKC´–dependent signals to inhibit hepatic insulin signal-
ing pathway in mammals with DIO.
FIG. 2. ATF4 mediates ER stress–induced expression of LIPIN2. A: Quantitative PCR analysis was performed with RNAs from mouse primary
hepatocytes. Cells were treated with DMSO, tunicamycin (1.25 mg/mL), or thapsigargin (0.5 mmol/L) for 24 h before being harvested. Represen-
tative data from four independent experiments are shown (n = 3 samples per group). B: Quantitative PCR analysis was performed with RNAs from
primary hepatocytes infected with either GFP control or ATF4 adenovirus (multiplicity of infection = 50) for 48 h. Representative data from three
independent experiments are shown (n = 3 samples per group). C and D: Luciferase assays of HepG2 cells transiently transfected with LIPIN2
reporter constructs. Cells were either treated with 0.5 mmol/L thapsigargin for 24 h (C), or cotransfected with 50 or 100 ng of ATF4 expression
plasmid for 48 h (D). Representative data from three independent experiments are shown (n = 3 samples per group). E: Chromatin immuno-
precipitation assay represents the occupancy of ATF4 on the LIPIN2 promoter in mouse primary hepatocytes. Thapsigargin (0.5 mmol/L) was
treated for 2 h. F: Quantitative PCR analysis for chromatin immunoprecipitation assay using liver lysates of wild-type mice. C57BL/6 mice were
injected intraperitoneally with either DMSO or tunicamycin (2.5 mg per g body wt, n = 3 per group), and livers were collected 2 h post-injection.
Error bars indicate SEM. Statistical signiﬁcance was assessed by two-tailed Student t test. *P < 0.05; **P < 0.01. Tuni, tunicamycin.
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ER stress has been linked to insulin resistance and meta-
bolic syndrome (34,35). Under conditions of physiological
ER stress such as over-nutrition or bacterial/viral in-
fection, UPR signaling in the liver is normally activated to
restore ER homeostasis. Prolonged ER stress might cause
irreversible defects in UPR signaling, and unresolved ER
stress would perturb lipid homeostasis to produce cellular
second messengers such as DAG or ceramides, and pro-
mote insulin resistance in the liver. ER stress–dependent
activation of transcription factors, such as ATF6, XBP1
and ATF4, have been implicated in this phenomenon both
in cultured cells and in vivo animal models.
Recent ﬁndings suggested that not all ER stress–linked
transcription factors are equally activated both in acute
and chronic ER stress conditions. Indeed, nuclear ATF6
and XBP1 levels in the liver are both diminished in diet-
induced or genetic mouse models of obesity, indicating
that these factors may not be actively involved in the pro-
gression of insulin resistance under chronic ER stress
conditions (10–12). Moreover, nuclear XBP1 is critical in
activating normal PI3 kinase–dependent signaling cascades,
FIG. 3. LIPIN2 deﬁciency reduces hyperglycemia and improves fatty liver in DIO mice. A: Four-hour fasting hepatic TAG levels (n = 10 for US and
n = 9 for shLIPIN2) from 12-week high-fat diet–fed mice that were injected with either Ad US (control) or Ad shLIPIN2 adenovirus. B and C: Four-
hour fasting hepatic DAG levels from mice as in A (n = 9 for US and n = 8 for shLIPIN2) (for total hepatic DAG levels [B] and for individual classes
of hepatic DAG [C]). D–F: Plasma TAG (D), plasma nonesteriﬁed fatty acid (E), and hepatic nonesteriﬁed fatty acid (F) levels from mice as in A
(n = 10 for US and n = 9 for shLIPIN2). G: Four-hour fasting plasma glucose levels from 12-week high-fat diet–fed mice injected with either Ad US
(control) or Ad shLIPIN2 adenovirus (n = 9 per each group). H: Four-hour fasting plasma insulin levels from 12-week high-fat diet–fed mice
injected with either Ad US (control) or Ad shLIPIN2 adenovirus (n = 3 for US, n = 4 for shLIPIN2). For the measurement of metabolites, 4-h fasted
mice were killed at day 7 after adenoviral injection. Error bars indicate SEM. Statistical signiﬁcance was assessed by two-tailed Student t test.
*P < 0.05; **P < 0.01. TG, triglyceride.
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cal initiator for hepatic insulin resistance in diet-induced or
genetic mouse models of obesity.
On the other hand, hepatic ATF4 expression is shown to
be increased upon high-fat diet (Fig. 1E and F). Furthermore,
ATF4 knock-out mice were resistant to DIO associated with
increased lipid oxidation and reduced glucose intolerance
(36,37). Thus, it is plausible to speculate that chronic ER
stress–induced activation of ATF4 or its downstream tran-
scription factor CHOP would be in part responsible for the
promotion of hepatic insulin resistance under the chronic
ER stress condition such as DIO. It is noteworthy to mention
that the involvement of other ER stress–induced pathways
under different pathological stimuli or in nonhepatic tissues
should also be considered in the progression of insulin re-
sistance to understand more completely the pathophysio-
logical consequences of chronic ER stress.
In this study, we demonstrated that hepatic LIPIN2 is
critical in ER stress–dependent regulation of lipid ho-
meostasis and insulin resistance in mouse models of DIO
(Fig. 6E for a proposed model). Both acute and chronic ER
stress conditions promote increased LIPIN2 transcription
via ATF4-dependent machineries. Although knockdown of
LIPIN2 in the liver ameliorates hepatic insulin resistance
and reduces hyperglycemic phenotypes in DIO mice,
overexpression of LIPIN2 with intact PAP activity greatly
promotes insulin resistance by inducing DAG production
and activity of PKC´ in the mouse liver. Activation of PKC´
FIG. 4. LIPIN2 deﬁciency in DIO mice improves glucose intolerance and insulin sensitivity. A–D: Glucose tolerance test (A) (2 g glucose per kg
body wt, n = 10 for US and n = 7 for shLIPIN2, using 4-h fasted mice at day 4 after adenoviral injection), plasma insulin levels during the glucose
tolerance (B), insulin tolerance (C) (1 unit insulin per kg body wt, n = 9 per each group, at day 5 after adenoviral injection), and pyruvate
challenge tests (D) (1 g glucose per kg body wt, n = 9 per each group, at day 4 after adenoviral injection) from mice as in Fig. 3. E: Western blot
assays using lysates from either Ad US– or Ad shLIPIN2–infected mouse livers as in Fig. 3. PBS (for control) or insulin (0.5 unit/kg body wt) was
injected intraperitoneally for 10 min before the collection of liver for Western blot assays on day 7 after adenoviral injection. Representative data
from two independent experiments (n = 6 for each condition) are shown. Error bars indicate SEM. Statistical signiﬁcance was assessed by two-
tailed Student t test. *P < 0.05; **P < 0.01.
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1078 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgFIG. 5. Overexpression of LIPIN2 deteriorates glucose and lipid homeostasis in DIO mice. A: Four-hour fasting hepatic TAG (n = 8 for GFP and
mutant LIPIN2 [L2 mut], and n = 9 for wild-type LIPIN2 [L2 wt]) from 12-week high-fat diet–fed mice injected with Ad GFP, Ad wild-type LIPIN2, or
Ad mutant LIPIN2. B and C: Four-hour fasting hepatic DAG levels from 12-week high-fat diet–fed mice infected with Ad GFP, Ad wild-type LIPIN2,
or Ad mutant LIPIN2 adenovirus (n = 7 for GFP and mutant LIPIN2 and n = 8 for wild-type LIPIN2) (for total hepatic DAG levels [B] and for
individual classes of hepatic DAG [C]). D–F: Plasma TAG (D), plasma nonesteriﬁed fatty acid (E), and hepatic nonesteriﬁed fatty acid (F) levels
from mice as in A (n = 8 for GFP and mutant LIPIN2, and n = 9 for wild-type LIPIN2). G and H: Four-hour fasting blood glucose (G)( n = 8 for GFP
and mutant LIPIN2, and n = 9 for wild-type LIPIN2) or 4-h fasting plasma insulin (H)( n = 4 for each group) was measured from 12-week high-fat
diet–fed mice injected with Ad GFP, Ad wild-type LIPIN2, or Ad mutant LIPIN2. For the measurement of metabolites, 4-h fasted mice were killed at
day 7 after adenoviral injection. Error bars indicate SEM. Statistical signiﬁcance was assessed by two-tailed Student t test. *P < 0.05; **P < 0.01.
TG, triglyceride.
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signaling cascades, which is in line with previous reports
showing that free fatty acid–dependent activation of PKC´
inhibits insulin receptor activity by a direct protein-protein
interaction (2,38). Interestingly, neither knockdown nor
overexpression of LIPIN2 greatly affects hepatic glucose
or lipid metabolism in normal chow-fed mice, suggesting
that the presence of adequate substrate (e.g., increased
hepatic fatty acid concentration due to over-nutrition rich
in fat) is prerequisite for the generation of excessive DAG,
which plays a role as a second messenger to perturb insulin
signaling. These data would illustrate the critical role of
LIPIN2 in mediating ER stress–dependent lipid accumulation
and the promotion of hepatic insulin resistance. Given the
predominant expression of LIPIN2 in the liver, it is plausible
to suggest that targeted disruption or selective inactivation of
this isoform is helpful to restore the normal insulin signaling
and glycemia under the chronic ER stress condition.
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FIG. 6. Overexpression of LIPIN2 perturbs hepatic insulin signaling in DIO mice. A–C: Glucose tolerance test (A) (2 g glucose per kg body wt, n =6
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tolerance test (B), and insulin tolerance test (C) (1 unit insulin per kg body wt, n = 8 for GFP and mutant LIPIN2 mutant, and n = 9 for wild-type
LIPIN2, at day 5 after adenoviral injection) from mice as in Fig. 5. D: Western blot assay using lysates from Ad GFP, Ad wild-type LIPIN2 (L2 wt),
or Ad mutant LIPIN2 (L2 mut) infected mouse livers as in Fig. 5. PBS (for control) or insulin (0.5 unit/kg body wt) was injected intraperitoneally
for 10 min before the collection of liver for Western blot assays on day 7 after adenoviral injection. Representative data from three independent
experiments (n = 6 for each condition) are shown. E: A proposed model for ER stress–induced activation of LIPIN2 in promoting DAG production
and the perturbation of hepatic insulin signaling. Error bars indicate SEM. Statistical signiﬁcance was assessed by two-tailed Student t test.
*P < 0.05; **P < 0.01; †P < 0.05; ‡P < 0.01.
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